The First and Only Recombinant Factor VIII Produced in Human Cells Without Chemical Modification or Protein Fusion1–6


NUWIQ is a 4th generation, B-domain-deleted recombinant Factor VIII treatment for Hemophilia A.5

  • Produced in human cells with no additional animal or human proteins2,6
  • Expresses only human post-translational modifications to more closely resemble the Factor VIII protein the body produces naturally2,6